Need for the assessment of dual diagnosis in prisons
DOI:
https://doi.org/10.20882/adicciones.165Keywords:
dual diagnosis, substance-use disorders, diagnosis, prisonAbstract
Introduction: Data show that 92.5% of prison inmates report drug or alcohol use. In spite of this, only 2% of dual diagnosis research has been carried out in the prison context. Therefore, the aim of this descriptive cross-sectional study was to analyze the profiles of dual diagnosis in a Spanish prison and test the feasibility of two assessment instruments. Method: The sample was made up of 152 drugaddicts imprisoned in the Villabona Penitentiary Center (Asturias, Spain) who volunteered to be interviewed. The sixth version of the Addiction Severity Index and the International Neuropsychiatric Interview –MINI– were used for the assessment of inmates’ psychopathological status and drug problems. Results: The results show that, in general, the offender’s profile is: male, 34 years old, unmarried, with children and with an average time spent in prison of approximately five years. Only 4.5% of respondents did not use drugs at the time of the study. In the remainder, the most widely used substances are cocaine (37.6%), heroin (29.9%) and alcohol (10.8%), with 52.7% reporting having used drugs in the last month. With regard to psychopathological state, only 12.9% have no associated disorders, and the most prevalent symptoms correspond to antisocial personality disorder (65.6%), risk of suicide (45.2%), depression (35.9%) and anxiety (25.5%). Conclusion: The instruments proposed (ASI-6 and MINI) are feasible tools for detecting addiction severity and associated psychopathology in this context.References
Asociación Española de Patología Dual -AEPD- (2008). Estudio epidemiológico para determinar la prevalencia diagnostico y actitud terapéutica de la patología dual en la Comunidad de Madrid. . Recuperado el día 4 de Noviembre de 2010 de http://www.madridsalud.es/noticias/Presentacion_espad_nov08.pdf.
Barea, J., Benito, A., Real, M., Mateu, C., Martín, E., López, N. y Haro, G.
(2010). Estudio sobre aspectos etiológicos de la patología dual. Adicciones, 22, 15-24.
Belenko, S. y Peugh, J. (2005). Estimating drug treatment needs among state prison inmates. Drug and Alcohol Dependence, 77, 269-281.
Bobes, J., Bascarán, M. T., Bobes-Bascarán, M. T., Carballo, J. L., Díaz
Mesa, E. M., Flórez, G., et al. (2007). Valoración de la gravedad de la adicción: aplicación a la gestión clínica y monitorización de los tratamientos. Madrid: Delegación del Gobierno para el Plan Nacional sobre Drogas.
Butler, T., Andrews, G., Allnutt, S., Sakashita, C., Smith, N. E. y Basson,
J. (2006). Mental disorders in Australian prisoners: a comparison with a community sample. Australian and New Zealand Journal of Psychiatry, 40, 272-276.
Cacciola, J.S. y Dugosh, K. (2003). Co-occurring substance use and
mental disorders: an annotated bibliography. Recuperado el día 4 de Noviembre de 2010 de: http://tie.samhsa.gov/Topics/Pdf/ annotatedbibliography.pdf
Cacciola, J.S., Alterman, A.I., Rutherford, M.J., McKay, J.R. y Mulvaney,
F.D. (2001). The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and alcohol dependence, 61, 271-80.
Carise, D., Gurel, O., Kendig, C. y McLellan, A. T. (2002). Giving Clinical Meaning to Patient Assessment: Technology Transfer to Improve Treatment Care Planning and Service Delivery. Philadelphia, PA.: Treatment Research Institute.
Casares-López, M.J., González, A., Torres, M., Secades, R., Fernández-
Hermida, J.R. y Álvarez, M. (2010). Comparación del perfil psicopatológico y adictivo de dos muestras de adictos en tratamiento: en prisión y en comunidad terapéutica. International Journal of Clinical and Health Psychology, 10, 225-243.
Casas, M. y Guardia, J. (2002). Patología psiquiátrica asociada al
alcoholismo. Adicciones, 14, 195-219.
Compton, W. M., Thomas, Y. F., Conway, K. P., y Colliver, J. D. (2005).
Developments in the epidemiology of drug use and drug use disorders. American Journal of Psychiatry, 162, 1494-1502.
Delegación del Gobierno para el Plan Nacional sobre Drogas (1999). Informe nº 2 del Observatorio Español sobre Drogas. Recuperado el día 4 de Noviembre de 2010 de http://www.pnsd.msc.es/Categoria2/publica/pdf/oed-2.pdf.
Delegación del Gobierno para el plan Nacional Sobre Drogas (2006).
Encuesta sobre salud y consumo de drogas a los internados en instituciones penitenciarias. Recuperado el día 9 de Julio de 2010 de http://www.pnsd.msc.es/Categoria2/publica/pdf/ encuestaPenitenciaria2006.pdf.
Delegación del Gobierno para el Plan Nacional sobre Drogas. (2008).
Informe de la encuesta domiciliaria sobre alcohol y drogas en España (EDADES) 2007/08. Madrid: Ministerio de Sanidad y Consumo.
Díaz-Mesa, E.M., García-Portilla, P., Sáiz, P., Bobes, T., Casares, M.J.,
Fonseca, E., Carreño, E., Florez, G., Guardía, J., Ochoa, E., Pereiro,
C., Rubio, G., Terán, A., Fernández-Hermida, J.R. y Bobes, J. (2010). Rendimiento psicométrico de la 6ª versión del Addiction Severity Index en español (ASI-6). Psicothema, 22, 513-519.
Dirección General de Instituciones Penitenciarias. Subdirección General de Sanidad Penitenciaria (2006). Estudio sobre Salud Mental en el medio penitenciario, Diciembre de 2006. Madrid: Subdirección General de Sanidad Penitenciaria.
Easton, C.J., Devine, S., Scott, M. y Wupperman, P. (2008). Commentary:
Implications for Assessment and Treatment of Addictive and Mentally Disordered Offenders Entering PrisonsJournal of the American Academy of Psychiatry and the Law, 36, 35 - 37.
Edens, J. F., Peters, R. H. y Hills, H. A. (1997). Treating prison inmates
with co-occurring disorders: An integrative review of existing programs. Behavioral Sciences & the Law, 15, 439-457.
Ferrando, L., Bobes, J., Gibert, J. y Lecrubier, Y. (1997). Mini International Neuropsychiatric Interview. En: Bobes J, Bousoño M, González MP, editores. Manejo de los trastornos mentales y del comportamiento en Atención Primaria. 2ª ed. Oviedo: Gofer; 1997.
Fanzel, S. y Dansen, J. (2002). Serious mental disorder in 23000 prisoners: a systematic review of 62 surveys. The Lancet, 16, 545-550.
Fotiadou, M., Livaditis, M., Manou, I., Kaniotou, E., y Xenitidis, K. (2006). Prevalence of mental disorders and deliberate selfharm in Greek male prisoners. International Journal of Law and Psychiatry, 29, 68–73.
Garrido, V. y Dorado, M. (2010). Trastorno antisocial de la personalidad y adicciones. En G. Haro, J. Bobes, M. Casas, J. Didia y G. Rubio (Eds.), Tratado sobre patología dual. Reintegrando la salud mental. Castellón: MRA.
Gelkopf, M., Weizman, T., Melamed, Y., Adelson, M. y Bleich, A. (2006).
Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic. Israel Journal of Psychiatry & Related Sciences, 43, 126-36.
González, F., Salvador, L., Martínez, J.M., López, A., Ruz Franzi I. y
Guerra, D. (2002). Estudio de fiabilidad y validez de la versión española de la entrevista clínica Addiction Severity Index (ASI). En: I. Iraurgi Castillo, F. González Sáiz (Eds.). Instrumentos de evaluación en drogodependencias (pp. 271-307). Barcelona: Aula Médica.
Gunter, T. D., Arndt, S., Wenman, G., Allen, J., Loveless, P., Sieleni, B., y
Black, D. W. (2008). Frequency of mental and addictive disorders among 320 men and women entering the Iowa prison system: use of the MINI-Plus. Journal of the American Academy of Psychiatry and the Law, 36, 27-34.
Harris, V., y Koepsell, T. D. (1998). Rearrest among mentally ill offenders. Journal of the American Academy of Psychiatry & the Law, 26, 393-402.
Kessler, R. C., Birnbaum, H., Demler, O., Falloon, I. R., Gagnon, E., Guyer,
M., Howes, M. J., Kendler, K. S., Shi, L., Walters, E. y Wu, E. Q. (2005). The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biological Psychiatry, 58, 668-676.
Kessler, R. C. y Merikangas, K. R. (2004). The National Comorbidity
Survey Replication (NCS-R): background and aims. International Journal of Methods in Psychiatric Research, 13, 60-68.
Lapham, S. C., Smith, E., C’De Baca, J., Chang, I., Skipper, B. J., Baum,
G. y Hunt, W. C. (2001). Prevalence of psychiatric disorders among persons convicted of driving while impaired. Archives of General Psychiatry, 58, 943-949.
Marshall, T., Simpson, S. y Stevens, A. (2000). Health Care in Prisons:
A Health Care Needs Assessment. University of Birmingham. Recuperado el día 6 de junio de 2010 de http://www.doh.gov.uk/prisonhealth/prisons.htm.
Millon, T. (1997). Millon Clinical Multiaxial Inventory-II (MCMI-II).
Minneapolis: National Computer Systems. National GAINS Center. (1999). Drug courts as a partner in mental health and co-occurring substance use disorders diversion programs. Delmar, NY: National GAINS Center.
NIAAA. Drinking in the United States: Main Findings from the 1992 National Longitudinal Alcohol Epidemiologic Survey (NLAES). National Institute on Alcohol Abuse and Alcoholism; 1998. NIH Publication No. 99-3519.
Pelissier, B. M., y O’Neil, J. A. (2000). Antisocial personality and depression among incarcerated drug treatment participants. Journal of Substance Abuse, 11, 379-393.
Peters, R. H., LeVasseur, M. E. y Chandler, R. K. (2004). Correctional
treatment for co-occurring disorders: results of a national survey. Behavioral Sciences and The Law, 22, 563-584.
Pettinati, H. M., Rukstalis, M. R., Luck, G. J., Volpicelli, J. R. y O’Brien,
C. P. (2000). Gender and psychiatric comorbidity: Impact on clinical presentation of alcohol dependence. American Journal on Addictions, 9, 242-252.
Piselli, M., Elisei, S., Murgia, N., Quartesan, R. y Abram, K. M. (2009).
Co-occurring psychiatric and substance use disorders among male detainees in Italy. International Journal of Law and Psychiatry, 32, 101-107.
Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L.
L. y Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Jama, 264, 2511-2518. Reglamento Penitenciario, aprobado por el Real Decreto 190/1996.
Rodríguez-Llera, M.C., Domingo, A., Brugal, M.T., Silva, T.C., Sánchez-
Niubó, A., Torrens, M., et al. (2006). Psychiatric comorbidity in young heroin users. Drug and Alcohol Dependence, 84, 48-55.
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J.,
Weiller, E., Hergueta, T., Baker, R. y Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59 Suppl 20, 22-33; quiz 34-57.
Simpler, A., y Langhinrichsen-Rohling, J. (2005). Substance use in prison: How much occurs and is it associated with psychopathology? Addiction Research and Theory, 13, 503–511.
Smith, H., Sawyer, D. A., y Way, B. B. (2002). Central New York Psychiatric Center: An approach to the treatment of co-occurring disorders in the New York State correctional mental health system. Behavioral Sciences & the Law, 20, 523-534.
Swanson, J.W., Holcer, C., Ganju, V. y Jono, R. (1990). Violence and
psychiatric disorder in the community. Hospital Community Psychiatry, 4, 101-137.
Swartz, J. A. y Lurigio, A. J. (1999). Psychiatric illness and comorbidity
among adult male jail detainees in drug treatment. Psychiatric Services, 50, 1628-1630.
White, M. D., Goldkamp, J. S., y Campbell, S. P. (2006). Co-Occurring
Mental Illness and Substance Abuse in the Criminal Justice System: Some Implications for Local Jurisdictions. The Prison Journal, 86, 301 - 326.
